oxybutynin has been researched along with Urinary Tract Infections in 13 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Urinary Tract Infections: Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Extended-release formulations of oxybutynin at 10 mg/d or tolterodine at 4 mg/d were given for 12 weeks to women with 21 to 60 urge urinary incontinence (UUI) episodes per week and an average of 10 or more voids per 24 hours." | 5.10 | Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. ( Appell, RA; Diokno, AC; Dmochowski, RR; Gburek, BM; Kell, SH; Klimberg, IW; Sand, PK, 2003) |
| "A retrospective analysis of patients with OAB who initiated treatment with tolterodine extended release (ER), oxybutynin ER, or oxybutynin immediate release (IR) between January 2001 and December 2002 was conducted to evaluate the frequency, relative risk, resource utilization, and costs related to three specific comorbidities associated with OAB: urinary tract infections (UTIs), depression, and fracture." | 3.73 | Retrospective evaluation of outcomes in patients with overactive bladder receiving tolterodine versus oxybutynin. ( Girase, P; Jumadilova, Z; Ollendorf, DA; Varadharajan, S, 2006) |
| "Terodiline is a new drug combining anticholinergic and calcium-blocking effects." | 2.38 | Functional daytime incontinence: pharmacological treatment. ( Chiozza, ML; Hjälmås, K; Passerini-Glazel, G, 1992) |
| "Oxybutynin is a tertiary amine and has chemical similarities like protamine sulfate." | 1.35 | Oxybutynin effects on Staphylococcus epidermidis biofilm production. ( Atmaca, S; Ersay, A; Gedik, A; Sener, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, L | 1 |
| Keys, C | 1 |
| Lam, JP | 1 |
| Harari, D | 1 |
| Igbedioh, C | 1 |
| Diokno, AC | 1 |
| Appell, RA | 1 |
| Sand, PK | 1 |
| Dmochowski, RR | 1 |
| Gburek, BM | 1 |
| Klimberg, IW | 1 |
| Kell, SH | 1 |
| Jumadilova, Z | 1 |
| Varadharajan, S | 1 |
| Girase, P | 1 |
| Ollendorf, DA | 1 |
| Gedik, A | 1 |
| Ersay, A | 1 |
| Atmaca, S | 1 |
| Sener, A | 1 |
| Koff, SA | 2 |
| Murtagh, DS | 1 |
| Murtagh, D | 1 |
| Bonney, WW | 1 |
| Robinson, RA | 1 |
| Theobald, RJ | 1 |
| Bensman, A | 1 |
| Deschenes, G | 1 |
| Audry, G | 1 |
| Grapin, C | 1 |
| Cowan, BE | 1 |
| Shortliffe, LM | 1 |
| Lin-Dyken, DC | 1 |
| Wolraich, ML | 1 |
| Hawtrey, CE | 1 |
| Doja, MS | 1 |
| Hjälmås, K | 1 |
| Passerini-Glazel, G | 1 |
| Chiozza, ML | 1 |
| Fanciullacci, F | 1 |
| Zanollo, A | 1 |
| Sandri, S | 1 |
| Catanzaro, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of the Efficacy and Tolerability of DITROPAN XL and DETROL LA in the Treatment of Overactive Bladder[NCT00293839] | Phase 3 | 790 participants (Actual) | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for oxybutynin and Urinary Tract Infections
| Article | Year |
|---|---|
[Bladder dysfunction in children].
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Infant; Male; Mandelic Acids; Parasympatholytic | 1995 |
Functional daytime incontinence: pharmacological treatment.
Topics: Butylamines; Calcium Channel Blockers; Child; Humans; Mandelic Acids; Parasympatholytics; Urinary In | 1992 |
1 trial available for oxybutynin and Urinary Tract Infections
| Article | Year |
|---|---|
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial.
Topics: Administration, Oral; Aged; Benzhydryl Compounds; Constipation; Cresols; Delayed-Action Preparations | 2003 |
10 other studies available for oxybutynin and Urinary Tract Infections
| Article | Year |
|---|---|
Bladder calculus formation on the tip of a migrated disused ventriculoperitoneal shunt.
Topics: Abnormalities, Multiple; Child; Cholinergic Antagonists; Combined Modality Therapy; Cystoscopy; Equi | 2013 |
Restoring continence in frail older people living in the community: what factors influence successful treatment outcomes?
Topics: Aged; Aged, 80 and over; Cognition Disorders; Comorbidity; Exercise; Female; Follow-Up Studies; Frai | 2009 |
Retrospective evaluation of outcomes in patients with overactive bladder receiving tolterodine versus oxybutynin.
Topics: Benzhydryl Compounds; Comorbidity; Cresols; Delayed-Action Preparations; Depression; Female; Fractur | 2006 |
Oxybutynin effects on Staphylococcus epidermidis biofilm production.
Topics: Biofilms; Catheters, Indwelling; Cholinergic Agents; Humans; Mandelic Acids; Staphylococcal Infectio | 2008 |
The uninhibited bladder in children: effect of treatment on recurrence of urinary infection and on vesicoureteral reflux resolution.
Topics: Adolescent; Anti-Infective Agents, Urinary; Child; Child, Preschool; Drug Combinations; Female; Huma | 1983 |
The uninhibited bladder in children: effect of treatment on vesicoureteral reflux resolution.
Topics: Adolescent; Anti-Infective Agents, Urinary; Child; Child, Preschool; Female; Humans; Male; Mandelic | 1984 |
Topical effect of intravesical oxybutynin.
Topics: Administration, Intravesical; Animals; Female; Mandelic Acids; Parasympatholytics; Rats; Ulcer; Urin | 1993 |
Oxybutynin decreases renal pelvic pressures in normal and infected rat urinary tract.
Topics: Animals; Cholinergic Antagonists; Female; Kidney Pelvis; Mandelic Acids; Pressure; Rats; Rats, Sprag | 1998 |
Follow-up of clean intermittent catheterization for children with neurogenic bladders.
Topics: Adolescent; Child; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Meningomyelocele; Parasy | 1992 |
The neuropathic bladder in children with spinal cord injury.
Topics: Catheterization; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Kidney Diseases; Male; | 1988 |